Profile: Bio Compression Systems, Inc. produces pneumatic sequential compression therapy equipment and therapeutic support surfaces. The bioarterial plus is an intermittent, sequential, pneumatic compression system that sequentially compresses both the foot and calf in patients suffering primarily from diabetic foot ulcers or intermittent claudication. The bioarterial plus system is designed to deliver bilateral pressures of 120 mmhg, almost 3 times the pressure of most DVT systems, for two to three treatments per day. The bioarterial plus system increases arterial blood flow in both the popliteal artery and at the tissue level. Substantial blood flow increases were realized through duplex ultrasonic imaging of the popliteal artery following treatment with the product. Through bilateral compression, resultant evacuation of venous blood from the lower limbs enables replacement with substantial volumes of oxygenated arterial blood.

The company was founded in 1983, has revenues of USD 5-10 Million, has ~20 employees and is CE certified.

FDA Registration Number: 2424387